Vitamin K2 And The Calcium Paradox: How a Little-Known Vitamin Could Save Your Life by Kate Rheaume-Bleue

Author:Kate Rheaume-Bleue [Rheaume-Bleue, Kate]
Language: eng
Format: azw3
Publisher: HarperCollins Canada
Published: 2013-06-25T04:00:00+00:00

Astute readers might be wondering about the mechanism by which menaquinone exerts its anticancer effects. Scientists are wondering, too. Many kinds of malignant tumors, including prostate and breast cancer, produce the vitamin K2–dependent matrix gla protein (MGP).27 Since most of the early research on MGP and cancer does not distinguish between carboxylated and undercarboxylated MGP, it is premature to say exactly what MGP does in cancerous tissue. That K2 deficiency is associated with more aggressive cancers strongly suggests that MGP left undercarboxylated is bad for cancer prognosis, just as it is bad for heart health. The controlling effect of vitamins A and D on MGP production is central to their cancer benefits. Certainly, the added benefit of K2 and D3 together hints at a relationship similar to that of bone and heart health, by which D3 increases MGP so that K2 can then activate it. Deciphering the riddle of vitamins A, D and K2 may one day unlock a vast potential in cancer prevention and treatment. It is possible that by producing menaquinone-dependent MGP, malignant tissue itself contains the solution to controlling cancer.

Download

Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.